Guide treatment selection
Submucosal fibroids often cause bleeding and may be removed hysteroscopically; intramural fibroids may respond to UAE; subserosal fibroids may require myomectomy or hysterectomy. Mapping determines the best approach.
Fibroid mapping is a specialised ultrasound assessment that systematically evaluates uterine fibroids (leiomyomas) – characterising their number, size, location, and relationship to the endometrial cavity. This detailed mapping is essential for planning treatment options, including medication, uterine artery embolisation (UAE), myomectomy, or hysterectomy.
Uterine fibroids are the most common benign tumours in women of reproductive age, affecting up to 70‑80% of women by age 50. While many fibroids are asymptomatic, others can cause heavy bleeding, pelvic pain, pressure symptoms, and infertility. Accurate fibroid mapping helps determine which treatment approach is most appropriate – whether the goal is symptom relief, fertility preservation, or definitive management.
At Amytri, our fibroid mapping is performed by experienced consultant radiologists using state‑of‑the‑art transvaginal and transabdominal ultrasound, often supplemented with saline infusion sonography (SIS) for enhanced cavity visualisation. We provide a detailed, diagrammatic report that documents each fibroid's size, position, and relationship to the endometrium and serosa – giving your gynaecologist the information needed to plan your treatment with confidence.
The location and characteristics of fibroids determine the most appropriate treatment approach – from medication to surgery.
Submucosal fibroids often cause bleeding and may be removed hysteroscopically; intramural fibroids may respond to UAE; subserosal fibroids may require myomectomy or hysterectomy. Mapping determines the best approach.
For women who wish to preserve fertility, mapping helps determine whether myomectomy is feasible – and whether it can be performed hysteroscopically, laparoscopically, or via open surgery.
Serial fibroid mapping can monitor growth over time or response to medical therapy (such as GnRH agonists or ulipristal acetate), guiding ongoing management.
We document fibroid features in a standardised format, using the FIGO classification system for consistency in treatment planning.
We document the total number of fibroids and measure each one in three dimensions (mm). This helps assess the overall uterine burden and predict treatment outcomes.
We specify the location of each fibroid – fundal, anterior, posterior, lateral, cervical, or broad ligament. This helps plan surgical approach and anticipate risks.
We classify fibroids using the FIGO (International Federation of Gynecology and Obstetrics) system – submucosal (0‑2), intramural (3‑5), or subserosal (6‑7). This standardised approach guides treatment decisions.
We assess the relationship of each fibroid to the endometrial cavity – cavity‑distorting fibroids (submucosal) are more likely to cause bleeding and infertility, and may be candidates for hysteroscopic resection.
We use colour Doppler to assess vascularity within and around each fibroid. High vascularity may suggest increased growth potential and may influence decisions about UAE.
We assess for signs of degeneration – calcification, cystic change, or hyaline degeneration – which can occur in larger fibroids and may cause pain or complications.
Your gynaecologist refers you for fibroid mapping – often due to symptoms like heavy bleeding, pelvic pressure, or an incidental finding on a previous scan.
We combine transabdominal (to assess the overall uterus and large fibroids) and transvaginal (for detailed localisation and characterisation) ultrasound. If needed, we may perform SIS to evaluate the endometrial cavity.
We systematically document each fibroid's number, size, location, classification, and relationship to the endometrium. We provide a diagrammatic report with clear visual representation.
We discuss the findings with you and your gynaecologist. The detailed map helps determine whether medical therapy, UAE, myomectomy, or hysterectomy is most appropriate.
If you have known fibroids or symptoms suggestive of them, detailed mapping provides essential information for management.
Submucosal fibroids are a common cause of heavy bleeding – mapping identifies whether fibroids are causing your symptoms.
Large fibroids can cause pressure symptoms – mapping identifies which fibroids are contributing and guides treatment decisions.
Cavity‑distorting fibroids can affect implantation and pregnancy outcomes – mapping is essential for planning fertility‑preserving surgery.
If you have known fibroids, serial mapping monitors growth and guides the timing of intervention.
Detailed mapping is essential for planning UAE – it helps identify the vascular supply to each fibroid and predict treatment response.
Pre‑operative mapping helps surgeons plan the approach, assess complexity, and counsel patients about risks and outcomes.
Dr. Abhishek has extensive experience in gynaecological ultrasound, with a special focus on uterine imaging and fibroid characterisation. He is skilled in transvaginal ultrasound, SIS, and Doppler assessment – providing the detailed, standardised mapping that guides surgical and interventional treatment decisions.
Fibroid mapping is often part of a treatment decision process – having your partner with you provides support and shared understanding.
We welcome partners to attend the ultrasound. We explain the findings, show you the fibroid locations on screen, and discuss the implications for treatment – helping both of you understand the options ahead.
Fibroid mapping is a dedicated ultrasound assessment that systematically evaluates uterine fibroids – documenting their number, size, location, classification, and relationship to the endometrial cavity to guide treatment decisions.
A routine pelvic ultrasound may detect fibroids, but fibroid mapping is a more detailed, systematic evaluation. It documents each fibroid individually with precise measurements, classification, and a diagrammatic report – specifically designed for treatment planning.
The ideal timing is days 5‑12 of the menstrual cycle, when the endometrium is thin and fibroids are most clearly visualised. However, it can be performed at any time if symptoms are present.
The FIGO classification is an international system for describing fibroid location – submucosal (0‑2), intramural (3‑5), and subserosal (6‑7). This standardised classification helps gynaecologists select the most appropriate treatment.
Yes, a referral from your gynaecologist is recommended. They will use the mapping results to plan your treatment, whether that's medication, UAE, myomectomy, or hysterectomy.
We will discuss the findings with you and your gynaecologist. Depending on your symptoms, age, and fertility wishes, options may include medication, uterine artery embolisation, myomectomy, or hysterectomy. The mapping helps determine which approach is most suitable.
From your baby's very first heartbeat to your family's lifelong health — we're here with precision, expertise and care. Reserve your appointment in under a minute.